HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nelson H Tsuno Selected Research

Neoplasm Metastasis (Metastasis)

3/2015Phosphatidylserine-specific phospholipase A1 (PS-PLA1) expression in colorectal cancer correlates with tumor invasion and hematogenous metastasis.
1/2015Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
2/2013The expression of phospholipase A2 group X is inversely associated with metastasis in colorectal cancer.
1/2013Colorectal cancer with multiple metachronous metastasis achieving complete remission 14 years after surgical resection: report of a case.
6/2010Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer.
2/2005Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial cell proliferation by induction of cell cycle arrest.
2/2005Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nelson H Tsuno Research Topics

Disease

35Neoplasms (Cancer)
03/2015 - 03/2002
16Colorectal Neoplasms (Colorectal Cancer)
03/2015 - 02/2008
10Colonic Neoplasms (Colon Cancer)
08/2012 - 01/2003
7Neoplasm Metastasis (Metastasis)
03/2015 - 02/2005
7Rectal Neoplasms (Rectal Cancer)
02/2015 - 01/2011
2Inflammation (Inflammations)
01/2015 - 06/2004
2Transfusion-Related Acute Lung Injury
12/2014 - 12/2013
2Neonatal Alloimmune Thrombocytopenia
04/2014 - 05/2010
2Thrombocytosis (Thrombocythemia)
04/2013 - 01/2012
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2012 - 10/2008
2Ulcerative Colitis
01/2011 - 01/2003
2Stomach Neoplasms (Stomach Cancer)
12/2008 - 08/2007
2Rheumatoid Arthritis
11/2007 - 11/2004
2Adenocarcinoma
02/2005 - 02/2005
1Surgical Wound Infection
05/2015
1Body Weight (Weight, Body)
12/2014
1Aplastic Anemia (Anemia, Hypoplastic)
04/2014
1Thrombocytopenia (Thrombopenia)
04/2014
1Transfusion Reaction
04/2014
1Sigmoid Neoplasms
01/2013
1Nephritis
11/2012
1Lupus Nephritis
11/2012
1Diabetes Mellitus
08/2012
1Adenoma (Adenomas)
08/2012
1Lymphatic Metastasis
04/2012
1Hypoxia (Hypoxemia)
03/2012
1Breast Neoplasms (Breast Cancer)
05/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2010
1Carcinoma (Carcinomatosis)
04/2010
1Ulcer
05/2009
1Proteinuria
10/2008

Drug/Important Bio-Agent (IBA)

5Fluorouracil (Carac)FDA LinkGeneric
08/2012 - 07/2010
4CytokinesIBA
01/2014 - 01/2003
4Proteins (Proteins, Gene)FDA Link
12/2012 - 02/2005
3Chloroquine (Aralen)FDA LinkGeneric
05/2014 - 07/2010
3AntigensIBA
04/2014 - 06/2006
3Biomarkers (Surrogate Marker)IBA
04/2013 - 01/2011
3sulforaphaneIBA
09/2010 - 01/2006
3plaunotolIBA
05/2009 - 04/2005
2AntibodiesIBA
12/2014 - 04/2014
2Calcibiotic Root Canal SealerIBA
12/2014 - 08/2012
2Blood Group Antigens (Blood Groups)IBA
04/2014 - 12/2006
2ChemokinesIBA
01/2014 - 07/2007
2IntegrinsIBA
06/2013 - 06/2010
2AutoantigensIBA
11/2012 - 10/2008
2AdiponectinIBA
04/2012 - 06/2003
2Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2012 - 01/2012
2Terpenes (Terpenoids)IBA
10/2010 - 08/2007
2Therapeutic UsesIBA
10/2010 - 05/2009
2isothiocyanic acidIBA
09/2010 - 02/2010
2DNA (Deoxyribonucleic Acid)IBA
06/2010 - 11/2004
2Antineoplastic Agents (Antineoplastics)IBA
05/2009 - 02/2009
2geranylgeraniolIBA
05/2009 - 08/2007
2CaspasesIBA
05/2009 - 05/2008
2Matrix Metalloproteinases (MMPs)IBA
05/2008 - 07/2007
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
02/2005 - 02/2005
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2005 - 02/2005
2Catechin (Z 7300)IBA
06/2004 - 11/2003
1PhosphatidylserinesIBA
03/2015
1Phospholipases A1 (Phospholipase A1)IBA
03/2015
1NucleoproteinsIBA
01/2015
1HMGB1 Protein (HMG1)IBA
01/2015
1LipopolysaccharidesIBA
12/2014
1Monoclonal AntibodiesIBA
12/2014
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2014
1TOR Serine-Threonine KinasesIBA
05/2014
1temsirolimusFDA Link
05/2014
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
12/2013
1Laminin ReceptorsIBA
06/2013
1Oxygen (Dioxygen)IBA
06/2013
1Group X Phospholipases A2IBA
02/2013
1anti-dsDNA autoantibodyIBA
11/2012
1UDPglucose-Hexose-1-Phosphate Uridylyltransferase (Galactose 1 P Uridyltransferase)IBA
08/2012
1Adiponectin ReceptorsIBA
04/2012
1Messenger RNA (mRNA)IBA
04/2012
1Hormones (Hormone)IBA
04/2012
1Irinotecan (Camptosar)FDA LinkGeneric
03/2012
1Indicators and Reagents (Reagents)IBA
01/2012
1Fibrinogen (Factor I)FDA Link
01/2011
1Carcinoembryonic AntigenIBA
01/2011
1C-Reactive ProteinIBA
01/2011
1geranylgeranylacetone (teprenone)IBA
10/2010
1Antimalarials (Antimalarial Agents)IBA
07/2010
1Laminin (Merosin)IBA
06/2010
1Human Platelet AntigensIBA
05/2010
1Serotonin (5 Hydroxytryptamine)IBA
04/2010
1mosaprideIBA
04/2010
1Hyaluronic Acid (Hyaluronan)IBA
12/2008
1Paclitaxel (Taxol)FDA LinkGeneric
12/2008
1AutoantibodiesIBA
10/2008

Therapy/Procedure

8Therapeutics
01/2015 - 05/2005
6Chemoradiotherapy
02/2015 - 01/2011
4Drug Therapy (Chemotherapy)
01/2013 - 01/2012
3Blood Transfusion (Blood Transfusions)
05/2015 - 12/2013
3Colectomy
01/2013 - 01/2011
3Immunotherapy
02/2008 - 03/2002
1Proctectomy
05/2015
1Neoadjuvant Therapy
02/2015
1Radiotherapy
01/2013
1Phototherapy (Light Therapy)
05/2011